Developer site: The content shown here is test data.

Health Dictionary AI Health Chat Find an Online Doctor
A serene Zen garden with raked sand and smooth stones, symbolising clarity and calm

Health Dictionary

Back to skin conditions

Hemolytic-uremic syndrome causes

Introduction

Overview

Overview

The major cause of HUS in childhood is gastrointestinal infection with verocytotoxin (Shiga-like toxin)-producing bacteria, usually enterohemorrhagic Escherichia coli (VTEC/STEC), and in some tropical regions Shigella dysenteriae type I.Verocytotoxin-producing citrobacter freundii has also been reported. Within STEC infections, risk is determined more precisely by Shiga toxin genotype than by serogroup alone; STEC that produce Shiga toxin 2 are high-risk pathogens. E. coli O157 remains the best-characterized high-risk STEC, but clinically important non-O157 STEC also occur. In America and the UK, most cases are associated with E. coli serotype O157:H7, while other serotypes such as O26, O111, O103, and O145 are increasingly reported in Europe and elsewhere.

VTEC strains produce various toxins, the major ones being verocytotoxin-1 (Stx1) and verocytotoxin-2 (Stx2). Verocytotoxin-1 differs by one amino acid from Shiga toxin produced by Shigella dysenteriae type 1. Verocytotoxin-2 has multiple variants that are closely related to each other but have 55–60% homology to verocytotoxin1. HUS is mostly caused by verocytotoxin-2-producing strains.HUS can occur in the course of systemic diseases or physiopathological conditions such as pregnancy, after transplantation or after drug assumption.

Among other infectious causes, Streptococcus pneumoniae and influenza virus are notable non-STEC triggers of HUS.

Causes

Causes

Common Causes

Common causes of HUS may include:[1][2][3][4]

Less Common Causes

Less common causes of HUS include [7][8][9][10]

Causes in Alphabetical Order

List the causes of the disease in alphabetical order:

References

References

  1. ↑ Shannon E. Majowicz, Elaine Scallan, Andria Jones-Bitton, Jan M. Sargeant, Jackie Stapleton, Frederick J. Angulo, Derrick H. Yeung & Martyn D. Kirk (2014). “Global incidence of human Shiga toxin-producing Escherichia coli infections and deaths: a systematic review and knowledge synthesis”. Foodborne pathogens and disease. 11 (6): 447–455. doi:10.1089/fpd.2013.1704. PMIDΒ 24750096. Unknown parameter |month= ignored (help)
  2. ↑ Chantal Loirat, Fadi Fakhouri, Gema Ariceta, Nesrin Besbas, Martin Bitzan, Anna Bjerre, Rosanna Coppo, Francesco Emma, Sally Johnson, Diana Karpman, Daniel Landau, Craig B. Langman, Anne-Laure Lapeyraque, Christoph Licht, Carla Nester, Carmine Pecoraro, Magdalena Riedl, Nicole C. A. J. van de Kar, Johan Van de Walle, Marina Vivarelli & Veronique Fremeaux-Bacchi (2016). “An international consensus approach to the management of atypical hemolytic uremic syndrome in children”. Pediatric nephrology (Berlin, Germany). 31 (1): 15–39. doi:10.1007/s00467-015-3076-8. PMIDΒ 25859752. Unknown parameter |month= ignored (help)
  3. ↑ Fadi Fakhouri, Julien Zuber, Veronique Fremeaux-Bacchi & Chantal Loirat (2017). “Haemolytic uraemic syndrome”. Lancet (London, England). 390 (10095): 681–696. doi:10.1016/S0140-6736(17)30062-4. PMIDΒ 28242109. Unknown parameter |month= ignored (help)
  4. ↑ Lopes da Silva, Rodrigo (2011). “Viral-associated thrombotic microangiopathies”. Hematology/Oncology and Stem Cell Therapy. 4 (2): 51–59. doi:10.5144/1658-3876.2011.51. ISSNΒ 1658-3876.
  5. ↑ http://www.who.int/news-room/fact-sheets/detail/e-coli
  6. ↑ Freedman SB, van de Kar NC, Tarr PI (October 2023). “Shiga Toxin-Producing Escherichia coli and the Hemolytic-Uremic Syndrome”. N Engl J Med. 389 (15): 1402–1414. doi:10.1056/NEJMra2108739. PMIDΒ 37819955 Check |pmid= value (help).
  7. ↑ P. J. Medina, J. M. Sipols & J. N. George (2001). “Drug-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome”. Current opinion in hematology. 8 (5): 286–293. PMIDΒ 11604563. Unknown parameter |month= ignored (help)
  8. ↑ Fadi Fakhouri, Lubka Roumenina, Francois Provot, Marion Sallee, Sophie Caillard, Lionel Couzi, Marie Essig, David Ribes, Marie-Agnes Dragon-Durey, Frank Bridoux, Eric Rondeau & Veronique Fremeaux-Bacchi (2010). “Pregnancy-associated hemolytic uremic syndrome revisited in the era of complement gene mutations”. Journal of the American Society of NephrologyΒ : JASN. 21 (5): 859–867. doi:10.1681/ASN.2009070706. PMIDΒ 20203157. Unknown parameter |month= ignored (help)
  9. ↑ Christine Skerka, Mihaly Jozsi, Peter F. Zipfel, Marie-Agnes Dragon-Durey & Veronique Fremeaux-Bacchi (2009). “Autoantibodies in haemolytic uraemic syndrome (HUS)”. Thrombosis and haemostasis. 101 (2): 227–232. PMIDΒ 19190803. Unknown parameter |month= ignored (help)
  10. ↑ FrΓ©meaux-Bacchi V (2013). “[Pathophysiology of atypical hemolytic uremic syndrome. Ten years of progress, from laboratory to patient]”. Biol Aujourdhui. 207 (4): 231–40. doi:10.1051/jbio/2013027. PMIDΒ 24594571.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sogand Goudarzi, MD [2]Parth Vikram Singh, MBBS